Novartis brought together European stakeholder including NGOs, academia, governments as well as Novartis associates to present and debate Novartis Access, a new program intended to increase access to medicine for patience at ever level of income. Novartis associates share their reactions.

Usage Rights & Restrictions

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.